Two Studies, Two Conclusions On The Differences Between Cypher And Taxus
This article was originally published in The Gray Sheet
Executive Summary
Two studies released last week take different perspectives on how to measure the differences between two fiercely competing products - Johnson & Johnson/Cordis' Cypher and Boston Scientific's Taxus drug-eluting stents